Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of TAS-108 in postmenopausal women with hormone receptor-positive breast cancer
jRCT2080221712Phase 2
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of TAS-108 in breast cancer (3 arms), sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
TAS-108
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT2080221712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221712.